Literature DB >> 8890254

Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis.

B Yasin1, R I Lehrer, S S Harwig, E A Wagar.   

Abstract

We tested 20 protegrins against Chlamydia trachomatis serovar L2 (L2/434/Bu). Five of the protegrins had native structures; the others included nonamidated, enantiomeric, and truncated variants and peptides with <2 disulfide bonds. Antichlamydial activity resided principally in residues 5 to 15 of native protegrin PG-1, and optimal activity required both intramolecular disulfide bonds.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8890254      PMCID： PMC174460          DOI： 10.1128/iai.64.11.4863-4866.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  11 in total

1.  Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.

Authors:  G Diamond; M Zasloff; H Eck; M Brasseur; W L Maloy; C L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 2.  Defensins and other endogenous peptide antibiotics of vertebrates.

Authors:  E Martin; T Ganz; R I Lehrer
Journal:  J Leukoc Biol       Date:  1995-08       Impact factor: 4.962

3.  Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.

Authors:  H Tamamura; T Murakami; S Horiuchi; K Sugihara; A Otaka; W Takada; T Ibuka; M Waki; N Yamamoto; N Fujii
Journal:  Chem Pharm Bull (Tokyo)       Date:  1995-05       Impact factor: 1.645

4.  Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.

Authors:  V N Kokryakov; S S Harwig; E A Panyutich; A A Shevchenko; G M Aleshina; O V Shamova; H A Korneva; R I Lehrer
Journal:  FEBS Lett       Date:  1993-07-26       Impact factor: 4.124

5.  Isolation of antimicrobial peptides from avian heterophils.

Authors:  E W Evans; G G Beach; J Wunderlich; B G Harmon
Journal:  J Leukoc Biol       Date:  1994-11       Impact factor: 4.962

6.  Gallinacins: cysteine-rich antimicrobial peptides of chicken leukocytes.

Authors:  S S Harwig; K M Swiderek; V N Kokryakov; L Tan; T D Lee; E A Panyutich; G M Aleshina; O V Shamova; R I Lehrer
Journal:  FEBS Lett       Date:  1994-04-11       Impact factor: 4.124

7.  Purification, primary structures, and antibacterial activities of beta-defensins, a new family of antimicrobial peptides from bovine neutrophils.

Authors:  M E Selsted; Y Q Tang; W L Morris; P A McGuire; M J Novotny; W Smith; A H Henschen; J S Cullor
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

Review 8.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells.

Authors:  R I Lehrer; A K Lichtenstein; T Ganz
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  Susceptibility of Neisseria gonorrhoeae to protegrins.

Authors:  X D Qu; S S Harwig; A M Oren; W M Shafer; R I Lehrer
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Epithelial antibiotics induced at sites of inflammation.

Authors:  B S Schonwetter; E D Stolzenberg; M A Zasloff
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728
View more
  16 in total

1.  Crystallization of antimicrobial pores in membranes: magainin and protegrin.

Authors:  L Yang; T M Weiss; R I Lehrer; H W Huang
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

Review 2.  Structural determinants of protein folding.

Authors:  Tse Siang Kang; R Manjunatha Kini
Journal:  Cell Mol Life Sci       Date:  2009-04-15       Impact factor: 9.261

3.  Haemophilus ducreyi is susceptible to protegrin.

Authors:  K Fortney; P A Totten; R I Lehrer; S M Spinola
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

4.  Improved activity of a synthetic indolicidin analog.

Authors:  T J Falla; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Activity of cathelicidin peptides against Chlamydia spp.

Authors:  Manuela Donati; Korinne Di Leo; Monica Benincasa; Francesca Cavrini; Silvia Accardo; Alessandra Moroni; Renato Gennaro; Roberto Cevenini
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

6.  Activity of protegrins against yeast-phase Candida albicans.

Authors:  Y Cho; J S Turner; N N Dinh; R I Lehrer
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Orientation and dynamics of an antimicrobial peptide in the lipid bilayer by solid-state NMR spectroscopy.

Authors:  S Yamaguchi; D Huster; A Waring; R I Lehrer; W Kearney; B F Tack; M Hong
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

8.  Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link.

Authors:  Hyunbum Jang; Fernando Teran Arce; Mirela Mustata; Srinivasan Ramachandran; Ricardo Capone; Ruth Nussinov; Ratnesh Lal
Journal:  Biophys J       Date:  2011-04-06       Impact factor: 4.033

9.  The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis.

Authors:  Narae Park; Kinrin Yamanaka; Dat Tran; Pete Chandrangsu; Johnny C Akers; Jessica C de Leon; Naomi S Morrissette; Michael E Selsted; Ming Tan
Journal:  J Antimicrob Chemother       Date:  2008-10-27       Impact factor: 5.790

10.  IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis.

Authors:  Lauren C Frazer; Amy M Scurlock; Matthew A Zurenski; Melissa M Riley; Margaret Mintus; Derek A Pociask; Jeanne E Sullivan; Charles W Andrews; Toni Darville
Journal:  Am J Reprod Immunol       Date:  2013-12       Impact factor: 3.886
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.